• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli companies.

    Shavit Capital has over $200 million under management across four separate private equity funds. Shavit Capital was founded in 2008 and the fourth fund was raised in 2017.  These Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Foamix plans $70m offering after acne trial success
    September 13, 2018
    Foamix's Acne Drug Meets Main Goals In Late-Stage Trial
    September 12, 2018
    Foamix jumps on positive Phase III acne trial results
    September 12, 2018
    Gamida Cell files for Nasdaq IPO
    September 2, 2018
    Gamida Cell expands its Orphan Drug Designation from the FDA for NiCord as a
    July 17, 2018
    New Promise for Bone-Marrow Transplants
    May 28, 2018
    Gamida Strengthens Leadership Team with Two New Appointments
    April 26, 2018
    Foamix Announces $16 Million Investment by OrbiMed
    April 16, 2018
    OrbiMed Invests $16m in Foamix
    April 16, 2018
    Mylan Invest in Mapi Pharma
    April 10, 2018